JP2005510521A5 - - Google Patents

Download PDF

Info

Publication number
JP2005510521A5
JP2005510521A5 JP2003543576A JP2003543576A JP2005510521A5 JP 2005510521 A5 JP2005510521 A5 JP 2005510521A5 JP 2003543576 A JP2003543576 A JP 2003543576A JP 2003543576 A JP2003543576 A JP 2003543576A JP 2005510521 A5 JP2005510521 A5 JP 2005510521A5
Authority
JP
Japan
Prior art keywords
polymer
sustained release
release composition
poly
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003543576A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005510521A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/036365 external-priority patent/WO2003041689A1/en
Publication of JP2005510521A publication Critical patent/JP2005510521A/ja
Publication of JP2005510521A5 publication Critical patent/JP2005510521A5/ja
Pending legal-status Critical Current

Links

JP2003543576A 2001-11-12 2002-11-12 生体適合性ポリマーブレンドおよびその使用 Pending JP2005510521A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33286801P 2001-11-12 2001-11-12
PCT/US2002/036365 WO2003041689A1 (en) 2001-11-12 2002-11-12 Biocompatible polymer blends and uses thereof

Publications (2)

Publication Number Publication Date
JP2005510521A JP2005510521A (ja) 2005-04-21
JP2005510521A5 true JP2005510521A5 (https=) 2006-01-05

Family

ID=23300202

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003543576A Pending JP2005510521A (ja) 2001-11-12 2002-11-12 生体適合性ポリマーブレンドおよびその使用

Country Status (6)

Country Link
US (1) US7282216B2 (https=)
EP (1) EP1443907A1 (https=)
JP (1) JP2005510521A (https=)
AU (1) AU2002343681B2 (https=)
CA (1) CA2466998A1 (https=)
WO (1) WO2003041689A1 (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040234472A1 (en) 2001-04-20 2004-11-25 Jackson John K. Micellar drug delivery systems for hydrophobic drugs
US6726918B1 (en) 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
AU2002236495B2 (en) 2000-11-29 2006-05-11 Allergan, Inc. Intraocular implants for preventing transplant rejection in the eye
FR2822834B1 (fr) * 2001-04-02 2005-02-25 Flamel Tech Sa Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation
FR2840614B1 (fr) * 2002-06-07 2004-08-27 Flamel Tech Sa Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
FR2843117B1 (fr) * 2002-07-30 2004-10-15 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
FR2860516B1 (fr) * 2003-10-03 2006-01-13 Flamel Tech Sa Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
FR2862541B1 (fr) * 2003-11-21 2007-04-20 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee d'interferons et leurs applications therapeutiques
FR2862535B1 (fr) * 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee d'interleukines et leurs applications therapeutiques
FR2862536B1 (fr) * 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
WO2005079856A1 (en) * 2004-02-23 2005-09-01 The University Of British Columbia Drug delivery compositions comprising hydrophobic polymers and amphipathic molecules
US8778014B1 (en) 2004-03-31 2014-07-15 Advanced Cardiovascular Systems, Inc. Coatings for preventing balloon damage to polymer coated stents
US20060198868A1 (en) * 2005-01-05 2006-09-07 Dewitt David M Biodegradable coating compositions comprising blends
US20060149363A1 (en) * 2005-01-06 2006-07-06 Scimed Life Systems, Inc. Optimally expanded, collagen sealed ePTFE graft with improved tissue ingrowth
EP1679065A1 (en) 2005-01-07 2006-07-12 OctoPlus Sciences B.V. Controlled release compositions for interferon based on PEGT/PBT block copolymers
US8192731B2 (en) * 2005-10-25 2012-06-05 Loctite (R&D) Limited Thickened cyanoacrylate compositions
WO2008157540A1 (en) * 2007-06-20 2008-12-24 Alkermes, Inc. Quench liquids and washing systems for production of microparticles
EP2175865A4 (en) 2007-07-25 2012-01-11 Biolex Therapeutics Inc INTERFERON DRUG PRODUCTS WITH CONTROLLED RELEASE AND TREATMENT OF HCV INFECTIONS THEREWITH
US9107815B2 (en) * 2008-02-22 2015-08-18 Allergan, Inc. Sustained release poloxamer containing pharmaceutical compositions
WO2010114770A1 (en) * 2009-03-30 2010-10-07 Cerulean Pharma Inc. Polymer-agent conjugates, particles, compositions, and related methods of use
WO2010114768A1 (en) * 2009-03-30 2010-10-07 Cerulean Pharma Inc. Polymer-epothilone conjugates, particles, compositions, and related methods of use
CN103932972A (zh) * 2009-03-30 2014-07-23 天蓝制药公司 聚合物-药剂缀合物、颗粒、组合物和相关使用方法
WO2010118238A2 (en) * 2009-04-08 2010-10-14 Surmodics, Inc. Controlled release devices and methods for delivery of nucleic acids
US8883208B2 (en) * 2009-04-08 2014-11-11 Surmodics, Inc. Particles for delivery of nucleic acids and related devices and methods
AU2011239742B2 (en) 2010-04-16 2014-11-27 Apatech Limited Biomaterial
US9173978B2 (en) 2010-09-22 2015-11-03 Ethicon, Inc. Bioabsorbable polymeric compositions, processing methods, and medical devices therefrom
US20130142878A1 (en) * 2011-12-01 2013-06-06 Flow Pharma, Inc. Peptide particle formulation
WO2013086419A1 (en) * 2011-12-09 2013-06-13 California Institute Of Technology Polymer scaffolds and their use in the treatment of vision loss
JP6177873B2 (ja) * 2012-03-30 2017-08-09 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル ミクロスフィア組成物、その調製方法及び用途
US20150044147A1 (en) * 2013-02-18 2015-02-12 King Abdullah International Medical Research Center Composition for management of periodontal disease
EP2986323A4 (en) * 2013-04-16 2016-10-19 Univ Case Western Reserve NEUTRALLY LOADED SYNTHETIC BLOOD PLATES TO REDUCE A COMPLEMENT REACTION
WO2015160706A1 (en) * 2014-04-14 2015-10-22 University Of Maryland, College Park Office Of Technology Commercialization Solution blow spun polymer fibers, polymer blends therefor and methods of use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE37983T1 (de) * 1982-04-22 1988-11-15 Ici Plc Mittel mit verzoegerter freigabe.
US5578323A (en) 1992-06-15 1996-11-26 Emisphere Technologies, Inc. Proteinoid carriers and methods for preparation and use thereof
US5330768A (en) * 1991-07-05 1994-07-19 Massachusetts Institute Of Technology Controlled drug delivery using polymer/pluronic blends
TW333456B (en) 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
GB9412273D0 (en) * 1994-06-18 1994-08-10 Univ Nottingham Administration means
ATE201983T1 (de) 1995-03-10 2001-06-15 Roche Diagnostics Gmbh Polypeptid-enthaltende pharmazeutische darreichungsformen in form von mikropartikeln und verfahren zu deren herstellung
US5709852A (en) * 1995-12-05 1998-01-20 Basf Corporation Ethylene oxide/propylene oxide/ethylene oxide (EO/PO/EO) triblock copolymer carrier blends
US5980948A (en) * 1996-08-16 1999-11-09 Osteotech, Inc. Polyetherester copolymers as drug delivery matrices
US6117949A (en) * 1998-10-01 2000-09-12 Macromed, Inc. Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
US6201072B1 (en) * 1997-10-03 2001-03-13 Macromed, Inc. Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
WO2001041735A2 (en) 1999-12-07 2001-06-14 Amgen Inc. Thermosensitive biodegradable hydrogels based on low molecular weight pluronics
US6296842B1 (en) * 2000-08-10 2001-10-02 Alkermes Controlled Therapeutics, Inc. Process for the preparation of polymer-based sustained release compositions

Similar Documents

Publication Publication Date Title
JP2005510521A5 (https=)
JP4907359B2 (ja) 生分解可能なマルチブロックコポリマー
JP2004502720A5 (https=)
EP2316490A3 (en) Methods and compositions for enhanced delivery of bioactive molecules
CA2339482C (en) Composite hydrogel drug delivery systems
US8652525B2 (en) NSAID delivery from polyarylates
US5665428A (en) Preparation of peptide containing biodegradable microspheres by melt process
US7901705B2 (en) Antimicrobial releasing polymers
JP2006516252A5 (https=)
US9028859B2 (en) Phase-separated block copolymer coatings for implantable medical devices
AU2002343681B2 (en) Biocompatible polymer blends and uses thereof
Huh et al. PLGA-PEG block copolymers for drug formulations
JP2010514474A5 (https=)
JP2003519194A5 (https=)
Bhardwaj et al. Interpenetrating polymer network (IPN): novel approach in drug delivery
JP2008272467A (ja) コーティングされたフィラメント
CN101522754A (zh) 用于医疗器械的可生物吸收聚合物组合物
Das et al. Colchicine encapsulation within poly (ethylene glycol)-coated poly (lactic acid)/poly (?-caprolactone) microspheres-controlled release studies
WO2007130134A3 (en) Controlled release microparticles
Tsung et al. Biodegradable polymers in drug delivery systems
JPWO2019013101A1 (ja) 自己拡張型ステントおよびその製造方法
Kırımlıoğlu History, introduction, and properties of PLGA as a drug delivery carrier
JP5927061B2 (ja) シート状止血材
Snežana et al. Polymeric matrix systems for drug delivery
CN1225014A (zh) 减少或消除术后粘着形成的方法和组合物